423 related articles for article (PubMed ID: 16179893)
1. Microalbuminuria and hypertension.
Reboldi G; Gentile G; Angeli F; Verdecchia P
Minerva Med; 2005 Aug; 96(4):261-75. PubMed ID: 16179893
[TBL] [Abstract][Full Text] [Related]
2. Hypertension and microalbuminuria: the new detrimental duo.
Verdecchia P; Reboldi GP
Blood Press; 2004; 13(4):198-211. PubMed ID: 15581333
[TBL] [Abstract][Full Text] [Related]
3. Microalbuminuria and tubular proteinuria as risk predictors of cardiovascular morbidity and mortality in essential hypertension: final results of a prospective long-term study (MARPLE Study)*.
Schrader J; Lüders S; Kulschewski A; Hammersen F; Züchner C; Venneklaas U; Schrandt G; Schnieders M; Rangoonwala B; Berger J; Dominiak P; Zidek W;
J Hypertens; 2006 Mar; 24(3):541-8. PubMed ID: 16467658
[TBL] [Abstract][Full Text] [Related]
4. Twelve shifting paradigms in diabetic renal disease and hypertension.
Mogensen CE
Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S2-9. PubMed ID: 18947897
[TBL] [Abstract][Full Text] [Related]
5. Microalbuminuria and cardiovascular risk.
Karalliedde J; Viberti G
Am J Hypertens; 2004 Oct; 17(10):986-93. PubMed ID: 15485765
[TBL] [Abstract][Full Text] [Related]
6. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
7. Left ventricular hypertrophy and clinical outcomes in hypertensive patients.
Ruilope LM; Schmieder RE
Am J Hypertens; 2008 May; 21(5):500-8. PubMed ID: 18437140
[TBL] [Abstract][Full Text] [Related]
8. Microalbuminuria: a common, independent cardiovascular risk factor, especially but not exclusively in type 2 diabetes.
Donnelly R; Yeung JM; Manning G
J Hypertens Suppl; 2003 Mar; 21(1):S7-12. PubMed ID: 12769161
[TBL] [Abstract][Full Text] [Related]
9. Left ventricular hypertrophy: how to influence an important risk factor in hypertension.
Agabiti-Rosei E; Muiesan ML
J Hypertens Suppl; 1998 Jan; 16(1):S53-8. PubMed ID: 9534098
[TBL] [Abstract][Full Text] [Related]
10. Microalbuminuria in essential hypertension.
Crippa G
J Hum Hypertens; 2002 Mar; 16 Suppl 1():S74-7. PubMed ID: 11986900
[TBL] [Abstract][Full Text] [Related]
11. [Microalbuminuria, hypertension, and cardiovascular risk].
Deferrari G; Pontremoli R
Cardiologia; 1994 Dec; 39(12 Suppl 1):159-62. PubMed ID: 7634260
[TBL] [Abstract][Full Text] [Related]
12. Influence of microalbuminuria in achieving blood pressure goals.
Duka I; Bakris G
Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):457-63. PubMed ID: 18695385
[TBL] [Abstract][Full Text] [Related]
13. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
[TBL] [Abstract][Full Text] [Related]
14. ESH-ESC guidelines for the management of hypertension.
Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
[TBL] [Abstract][Full Text] [Related]
15. Association of heart rate with microalbuminuria in cardiovascular risk patients: data from I-SEARCH.
Böhm M; Reil JC; Danchin N; Thoenes M; Bramlage P; Volpe M
J Hypertens; 2008 Jan; 26(1):18-25. PubMed ID: 18090536
[TBL] [Abstract][Full Text] [Related]
16. Microalbuminuria in essential hypertension: significance, pathophysiology, and therapeutic implications.
Bianchi S; Bigazzi R; Campese VM
Am J Kidney Dis; 1999 Dec; 34(6):973-95. PubMed ID: 10585306
[TBL] [Abstract][Full Text] [Related]
17. Association of cardiovascular risk factors with microalbuminuria in hypertensive individuals: the i-SEARCH global study.
Böhm M; Thoenes M; Danchin N; Bramlage P; La Puerta P; Volpe M
J Hypertens; 2007 Nov; 25(11):2317-24. PubMed ID: 17921828
[TBL] [Abstract][Full Text] [Related]
18. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
de Zeeuw D
Semin Nephrol; 2007 Mar; 27(2):172-81. PubMed ID: 17418686
[TBL] [Abstract][Full Text] [Related]
19. Association between high-normal albuminuria and risk factors for cardiovascular and renal disease in essential hypertensive men.
Dell'Omo G; Penno G; Giorgi D; Di Bello V; Mariani M; Pedrinelli R
Am J Kidney Dis; 2002 Jul; 40(1):1-8. PubMed ID: 12087554
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of abnormal urinary albumin excretion rate in hypertensive patients with impaired fasting glucose and its association with cardiovascular disease.
Marín R; Rodríguez P; Tranche S; Redón J; Morales-Olivas F; Galgo A; Brito MA; Mediavilla J; Lozano JV; Filozof C;
J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S178-88. PubMed ID: 17130259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]